Cargando…
Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation
PURPOSE: Of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT), 75 % or more experience oral mucositis, a painful acute complication that can delay discharge, interrupt treatment, and threaten life. To evaluate the efficacy of a supersaturated calcium phosphate rinse (SCPR...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411282/ https://www.ncbi.nlm.nih.gov/pubmed/22736463 http://dx.doi.org/10.1007/s00520-012-1489-5 |
_version_ | 1782239803072315392 |
---|---|
author | Markiewicz, Miroslaw Dzierzak-Mietla, Monika Frankiewicz, Andrzej Zielinska, Patrycja Koclega, Anna Kruszelnicka, Malgorzata Kyrcz-Krzemien, Slawomira |
author_facet | Markiewicz, Miroslaw Dzierzak-Mietla, Monika Frankiewicz, Andrzej Zielinska, Patrycja Koclega, Anna Kruszelnicka, Malgorzata Kyrcz-Krzemien, Slawomira |
author_sort | Markiewicz, Miroslaw |
collection | PubMed |
description | PURPOSE: Of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT), 75 % or more experience oral mucositis, a painful acute complication that can delay discharge, interrupt treatment, and threaten life. To evaluate the efficacy of a supersaturated calcium phosphate rinse (SCPR), we compared it with customary care—topical mouth solutions—on measures of severity and consequent interventions and complications. METHODS: In this randomized controlled trial, 40 patients undergoing allogeneic HSCT were randomized: 20 to SCPR four times daily and 20 to solutions made with salvia leaf extract, iodine-povidine, and fluconazole. Treatment extended from initiation of conditioning treatment until the granulocyte count was ≥0.2 g/L. Mucositis severity was measured daily by a hematologist according to a World Health Organization (WHO) scale and self-assessed by patients. Need for interventions [analgesics, total parenteral nutrition (TPN), and granulocyte colony-stimulating factor] and complications (acute graft-versus-host disease and infections) were also assessed. RESULTS: In comparison with the control group, the SCPR group had significantly lower mean measures of WHO oral toxicity (0.9 vs. 1.8; P = 0.02), disease course (3.2 vs. 7.1 days; P = 0.02), and peak mouth pain (0.85 vs. 1.75; P = 0.005). Analgesic need was significantly shorter (1.1 vs. 3.4 days; P = 0.047) and the need for TPN significantly lower (0 vs. 6 patients; P = 0.02; 0 vs. 1.9 mean days; P = 0.009). Measures of complications were lower in the SCPR group, but not significantly so. Trial limitations include the impracticality of achieving double blinding with agents so different in appearance and in preadministration preparation. CONCLUSIONS: Compared with the control group, the SCPR group had significantly lower mean measures of oral toxicity, peak mouth pain, and disease course duration. These results warrant confirmation in controlled, multicenter, randomized trials. |
format | Online Article Text |
id | pubmed-3411282 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-34112822012-08-23 Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation Markiewicz, Miroslaw Dzierzak-Mietla, Monika Frankiewicz, Andrzej Zielinska, Patrycja Koclega, Anna Kruszelnicka, Malgorzata Kyrcz-Krzemien, Slawomira Support Care Cancer Short Communication PURPOSE: Of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT), 75 % or more experience oral mucositis, a painful acute complication that can delay discharge, interrupt treatment, and threaten life. To evaluate the efficacy of a supersaturated calcium phosphate rinse (SCPR), we compared it with customary care—topical mouth solutions—on measures of severity and consequent interventions and complications. METHODS: In this randomized controlled trial, 40 patients undergoing allogeneic HSCT were randomized: 20 to SCPR four times daily and 20 to solutions made with salvia leaf extract, iodine-povidine, and fluconazole. Treatment extended from initiation of conditioning treatment until the granulocyte count was ≥0.2 g/L. Mucositis severity was measured daily by a hematologist according to a World Health Organization (WHO) scale and self-assessed by patients. Need for interventions [analgesics, total parenteral nutrition (TPN), and granulocyte colony-stimulating factor] and complications (acute graft-versus-host disease and infections) were also assessed. RESULTS: In comparison with the control group, the SCPR group had significantly lower mean measures of WHO oral toxicity (0.9 vs. 1.8; P = 0.02), disease course (3.2 vs. 7.1 days; P = 0.02), and peak mouth pain (0.85 vs. 1.75; P = 0.005). Analgesic need was significantly shorter (1.1 vs. 3.4 days; P = 0.047) and the need for TPN significantly lower (0 vs. 6 patients; P = 0.02; 0 vs. 1.9 mean days; P = 0.009). Measures of complications were lower in the SCPR group, but not significantly so. Trial limitations include the impracticality of achieving double blinding with agents so different in appearance and in preadministration preparation. CONCLUSIONS: Compared with the control group, the SCPR group had significantly lower mean measures of oral toxicity, peak mouth pain, and disease course duration. These results warrant confirmation in controlled, multicenter, randomized trials. Springer-Verlag 2012-06-27 2012 /pmc/articles/PMC3411282/ /pubmed/22736463 http://dx.doi.org/10.1007/s00520-012-1489-5 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Short Communication Markiewicz, Miroslaw Dzierzak-Mietla, Monika Frankiewicz, Andrzej Zielinska, Patrycja Koclega, Anna Kruszelnicka, Malgorzata Kyrcz-Krzemien, Slawomira Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation |
title | Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation |
title_full | Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation |
title_fullStr | Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation |
title_full_unstemmed | Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation |
title_short | Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation |
title_sort | treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411282/ https://www.ncbi.nlm.nih.gov/pubmed/22736463 http://dx.doi.org/10.1007/s00520-012-1489-5 |
work_keys_str_mv | AT markiewiczmiroslaw treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation AT dzierzakmietlamonika treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation AT frankiewiczandrzej treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation AT zielinskapatrycja treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation AT koclegaanna treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation AT kruszelnickamalgorzata treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation AT kyrczkrzemienslawomira treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation |